The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
November 22nd 2024
Children with obesity, asthma, and gastrointestinal disease had longer durations of stays compared with children without comorbidities.
Lead Investigator Provides Insight Into FDA Approval of Momelotinib for Myelofibrosis
September 29th 2023Ruben A. Mesa, MD, FACP, discusses the results of the SIMPLIFY-1 and MOMENTUM trials and how the data led to the approval of momelotinib to treat intermediate or high-risk myelofibrosis in adult patients with anemia.
Watch
Trial Results Find Enfortumab Vedotin-ejfv, Pembrolizumab Combination Effective in Urothelial Cancer
September 28th 2023The combined enfortumab vedotin-ejfv and pembrolizumab treatment is recommended for patients with locally advanced or metastatic urothelial cancer who are ineligible for cisplatin-containing therapy.
Read More
Possible Link Between Depression, Limited Social Interactions During COVID-19 Pandemic
September 28th 2023Study findings showed a 10% increase in the proportion of individuals staying home due to COVID-19 policy restrictions being associated with a 0.27 increase in PHQ-9 scores for depression.
Read More
Independent Pharmacy Files Lawsuit Against CVS Health, Caremark, Aetna Based on DIR Fees
September 28th 2023The National Community Pharmacists Association said the action was sent into motion by wrongful penalties for Medicare Part D prescriptions, called pharmacy direct and indirect remuneration fees.
Read More
Bosutinib Approved by FDA for Pediatric Patients With Chronic Myelogenous Leukemia
September 27th 2023Bosutinib (Bosulif) is indicated to treat pediatric patients with Philadelphia chromosome–positive chronic-phase chronic myelogenous leukemia that is newly diagnosed, resistant, or intolerant to previous therapy.
Read More
Large Review Suggests IVIG is Effective for Neurological Diseases Following COVID-19 Infection
September 27th 2023Intravenous immunoglobulin found to provide fast and long-lasting relief for COVID-19-related neurological conditions, although investigators are still uncovering the pathology of many of these conditions.
Read More
Enfortumab Vedotin-ejfv, Pembrolizumab Combination Shows Promise Treating Urothelial Cancer
September 26th 2023Investigators reported that enfortumab vedotin-ejfv (Padcev; Astella Pharma Inc, Seagen Inc) in combination with pembrolizumab (Keytruda; Merck & Co Inc) met the dual primary endpoints of overall survival and progression-free survival in patients with previously untreated locally advanced or metastatic urothelial cancer.
Read More
COVID-19 Pandemic Associated With Worsening Mental Health Outcomes for Adolescents
September 25th 2023To promote positive mental health outcomes, researchers urge for policy interventions that focus on home connectedness, peer friendship, and school climate while avoiding full school closures.
Read More
Survey: 72% of Pharmacy Technicians’ Workflow Affected by Drug Shortages
September 22nd 2023Chemotherapy, medication for attention deficit/hyperactivity disorder, glucagon-like peptide-1 agonists for weight loss and diabetes, and local anesthetics were among the drugs most affected by shortages.
Read More